Posted Jun. 4, 2012 at 12:27 p.m.

Premium Lock Setbacks precede resignation of Targacept co-founder

Published: 2012-06-04 12:27:35
Updated: 2012-06-04 12:27:35

Targacept's HQ Targacept's HQ Image 1 of 2 · Next Image…

Don deBethizy is stepping down as CEO and chairman of the drug development company. DeBethizy said he "decided to step down for personal considerations." But the move follows some setbacks for the company, most prominent the phase 3 failure of the company's lead drug, a depression treatment....

Read More
Read More

WRAL TechWire any time: Twitter, Facebook

Copyright 2017 MedCity. All rights reserved.
Editor's Blog

Editor's Blog

The latest blog posts from our WRAL TechWire and WRAL editors. Read more articles…

Please Log In to add a comment.

Latest for Insiders